• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Oncology/Infection

The following trials provide information to treat various types of cancer and infectious disease, both for ongoing and completed clinical trials.  For more information on our oncology therapy area please click here or for our infection therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • expand A Phase I/Ib, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of AZD9150 in Patients with Advanced/Metastatic Hepatocellular Carcinoma
    Study Id
    D5660C00001
    Disease
    hepatocellular carcinoma
    Study Name
    D5660C00001
    Recruiting Status
    Not Yet Recruiting
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Two-part, Randomised, Open-label, Multicentre, Phase I Study to Determine the Effect of Food on the Pharmacokinetics of Olaparib Following Single 400 mg Doses of the Capsule Formulation in Patients with Advanced Solid Tumours
    Study Id
    D081AC00001
    Disease
    solid tumour
    Drug Name
    Olaparib
    Study Name
    D081AC00001
    Recruiting Status
    Not Yet Recruiting
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chemotherapy
    Study Id
    D0818C00001
    Disease
    ovarian cancer
    Drug Name
    Olaparib
    Recruiting Status
    Not Yet Recruiting
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Randomised, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer
    Study Id
    D1532C00065
    Disease
    thyroid cancer
    Drug Name
    AZD6244
    Study Name
    D1532C00065
    Recruiting Status
    Not Yet Recruiting
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013